TOLERANCE TO PENTYLENTETRAZOL-INDUCED CONVULSIONS AND PROTECTION OF CEREBROVASCULAR INTEGRITY BY CHRONIC NICOTINE

REFERENCES

• Ates, N., Üzüm, G., Diler, A. S., & Ziylan, Y. Z. (1992). The cerebrovascular permeability and epilepsy: The role of blood pressure. Neuroscience Research Communications, 10, 163–169.
   Google Scholar
• Barrios, V., Rodriguez-Sanchez, M. N., Colas, B., & Arilla, E. (1990). Effects of acute nicotine and mecamylamine administration on somatostatin concentration and binding in the rat brain. European Journal of Pharmacology, 25, 263–270.
   Google Scholar
• Belluarda, N., Mudo, G., Blum, M., & Fuxe, K. (2000). Central nicotinic receptors, neu-rotrophic factors and neuroprotection. Behavioral Brain Research, 113, 21–24.
   PubMed Web of Science ®Google Scholar
• Bertrand, D., Picard, F., LeHellard, S., Weiland, S., Favre, I., Phillips, H., Bertrand, S., Berkovic, S. F., Malafose, A. & Mulley, J. (2002). How mutations in the nAChRs can cause ADNFLE epilepsy. Epilepsia, 43, 112–122.
   Google Scholar
• Borlongan, C. V., Shytle, R. D., Ross, S. D., Shimizu, T., Freeman, T. B., Cahill, D. W., & Sanberg, P. R. (1995). (-)Nicotine protects against systemic kainic acid-induced excitotoxic effects. Experimental Neurology, 136, 261–265.
   PubMed Web of Science ®Google Scholar
• Buisson, B., & Bertrand, D. (2001). Chronic exposure to nicotine upregulates the human (alpha)4 (beta)2nicotinic acetylcholine receptor function. Journal of Neuroscience, 15, 1819–1829.
   Google Scholar
• Collins, A. C., Evans, L. L., Miner, L. L., & Marks, M. J. (1986). Mecamylamine block-ade of nicotine responses: Evidence for two brain nicotinic receptors. Pharmacology Biochemistry Behavioral, 24, 1767–1773.
   PubMed Web of Science ®Google Scholar
• Dagci, I., Tan, M., Koylu, E. O., Tan U., & Pogun, S. (2002). The effect of octreotide on kainite-induced wet dog shakes and seizure activity in male and female rats. Interna-tional Journal of Neuroscience, 112, 829–839.
   PubMed Web of Science ®Google Scholar
• Damaj, M. I., Glassco, M., Dukat, M., & Martin, B. R. (1999). Pharmacological character-ization of nicotine-induced seizures in mice. Journal of Pharmacology & Experimen-tal Therapeutics, 291, 1284–1291.
   PubMed Web of Science ®Google Scholar
• Dani, J. A. (2000). Properties underlying the influence of nicotinic receptors on neuronal excitability and epilepsy. Epilepsia, 41, 1063–1065.
   PubMed Web of Science ®Google Scholar
• Fusco, M. D., Becchetti, A., Patrignani, A., Annesi, G., Gambardella, A., Quattrone, A., Ballabio, A., Wanke, E., & Casari, G. (2000). The nicotinic receptor β2 subunit is mutant in nocturnal frontal lobe epilepsy. Nature Genetics, 26, 275–276.
   PubMed Web of Science ®Google Scholar
• Hendryk, S., Jedrzejowska Szypulka, H., Josko, J., Jarzab, B., & Döhler, K. D. (2002). Influence of the corticotrophin releasing hormone (CRH) on the brain-blood barrier permeability in cerebral ischemia in rats. Journal of Physiology & Pharmacology, 53(1), 85–94.
   PubMed Web of Science ®Google Scholar
• Hosli, E., & Hosli, E. (1994). Colocalization of binding sites for somatostatin, muscarine and nicotine on cultured neurons of rat neocortex, cerebellum, brain stem and spinal cord: Combined autoradiographic and immunohistochemical studies. Neuroscience Letter, 173, 71–74.
   PubMed Web of Science ®Google Scholar
• Hulien-Gublin, B. A., Lumpkin, M. D., & Kellar, K. J. (1990). Effects of chronic admin-istration of nicotine on prolactin release in the rat: Inactivation of prolactin response by repeated injections of nicotine. Journal Pharmacology & Experimental Therapeu-tics, 252, 21–25.
   PubMed Web of Science ®Google Scholar
• Jones, S., Sudweeks, S., & Yakel, J. L. (1999). Nicotinic receptors in the brain: Correlat-ing physiology with function. Trends in Neurosciences, 2, 555–561.
   Google Scholar
• Ke, L., Eisenhour, C. M. Bencherif, M., & Lukas, R. J. (1998). Effects of chronic nico-tine treatment on expression of diverse nicotinic acetylcholine receptor subtypes. I. Dose-and time-dependent effects of nicotine treatment. Journal Pharmacology & Ex-perimental Therapeutics, 286, 825–840.
   PubMed Web of Science ®Google Scholar
• Kim, H.-C., Jhoo, W.-K., HoKo, K., Kim, W.-K., Bing, G., Kwon, M.-S., Shin, E.-J., Suh, J.-H., Lee, Y.-G., & Lee, D.-W. (2000). Prolonged exposure to cigarette smoke blocks the neurotoxicity induced by kainic acid in rats. Life Sciences, 66, 317–326.
   PubMed Web of Science ®Google Scholar
• Klatzo, I. (1983). Disturbances of the blood-brain barrier in cerebrovascular disorders. Acta Neuropathologica Supplementum, 8, 81–88.
   PubMedGoogle Scholar
• McDonough, J. H., & Shih, T. M. (1995). A study of the N-methyl-D-aspartate antagonis-tic properties of anticholinergic drugs. Pharmacology Biochemistry Behavior, 51, 249–253.
   PubMed Web of Science ®Google Scholar
• Nelson, S., & Manz, M. (1971). Use of specific gravity in the measurement of cerebral edema. Journal Applied Physiology, 30, 268–271.
   PubMed Web of Science ®Google Scholar
• Newman, M. B., Manresa, J. J., Sanberg, P. R., &. Shytle, D. (2001). Nicotine induced seizures blocked by mecamylamine and its stereoisomers. Life Sciences, 69, 2583-2591. Papke, R. L., Sanberg, P. R., & Shytle, R. D. (2001). Analysis of mecamylamine stereoi-somers on human nicotinic receptor subtypes. Journal of Pharmacology and Experi- mental Therapeutics, 297, 646–656.
   PubMed Web of Science ®Google Scholar
• Pogun. S., Demirgoren, S., Taskiran, D., Kanit, L., Yilmaz, O., Koylu, E., Balkan, B., & London, E. D. (2000). Nicotine modulates nitric oxide in rat brain. European Neuropsychopharmacology, 10, 463–472.
   PubMed Web of Science ®Google Scholar
• Prendergast, M. A, Harris, B. R., Mayer, S., Holley, R. C., Pauly, J. R., & Littleton, J. M. (2001). Nicotine exposure reduces N-methyl-D-aspartate toxicity in the hippocampus: Relation to distribution of the alpha 7 nicotinic acetylcholine receptor subunit. Medi-cal Science Monitoring, 7(6), 1153–1160.
   PubMedGoogle Scholar
• Rössner, N., & Tempel, K. (1966). Quantitative Bestimmung der Permeabilitat dersagenonnten blut-hirnschranke für Evans-blue (tl824). Medical Pharmacology Experimental, 14, 169–182.
   PubMed Web of Science ®Google Scholar
• Shytle, R. D., Borlongan, C. V., & Sanberg, P. R. (1995). Nicotine blocks kainic acid-induced wet dog shakes in rats. Neuropsychopharmacology, 13, 261–264.
   PubMed Web of Science ®Google Scholar
• Summers, K. L., & Glacabini, E. (1995). Effects of local and repeated systemic adminis-tration of (-) nicotine on extracellular levels of acetylcholine, norepinephrine, dopam-ine, and serotonin in rat cortex. Neurochemical Research, 20, 753–759.
   PubMed Web of Science ®Google Scholar
• Tan, M., Kalyoncu, N. I., & Tan, U. (2002). Sex difference in susceptibility to picrotoxine-induced seizures in rats following octreotide. International Journal of Neuroscience, 112, 903–911.
   PubMed Web of Science ®Google Scholar
• Üzüm, G., Diler, A. S., & Ziylan, Y. Z. (1999). Chronic nicotine pretreatment protects the blood-brain barrier against nicotine-induced seizures in the rat. Pharmacological Re-search, 40, 263–269.
   Google Scholar
• Üzüm, G., Curgunlu, S., Hacialioglu, M., Ercan, S., Diler, A. S., & Ziylan, Y. Z. (1993). Protective effect of chronic administration of nicotine on neuronal and vascular func-tions in the brain. European Journal Neuroscience Supplementum, 6, 93.
   Google Scholar
• Vezzani, A., & Hoyer, D. (1999). Brain somatostatin: A candidate inhibitory role in sei-zures and epileptogenesis. European Journal of Neuroscience, 11, 3767–3776.
   PubMed Web of Science ®Google Scholar
• Young, J. M., Shytle, R. D., Sanberg, P. R., & George, T. P. (2001). Mecamylamine: New therapeutic uses and toxicity/risk profile. Clinical Theraupetics, 23, 532–565.
   PubMed Web of Science ®Google Scholar
• Zevin, S., Jacob, P., & Benowitz, N. L. (2000). Nicotine-mecamylamine interactions. Clinical Pharmacology Theraupetics, 68, 58–66.
   PubMed Web of Science ®Google Scholar
• Ziylan, Y. Z., Lefauconnier, J. M., Bernard, G., & Bourre, J. M. (1993). Hormonal influ-ence on permeability of the blood-brain barrier: Effect of an analog of adrenocortico-tropic hormone, beta 1-24 corticotropin. Neuroscience Letter, 51, 59–63.
   Google Scholar
• Ziylan, Y. Z., & Ates, N. (1989). Age-related changes in regional patterns of blood-brain barrier breakdown during epileptiform seizures induced by pentylentetrazole. Neuro-science Letter, 96, 179–184.
   PubMed Web of Science ®Google Scholar